Protective efficacy and the recovery profile of certain chemoprotectants against lethal poisoning by microcystin-LR in mice.

The cyclic peptide toxins microcystins and nodularins are the most common and abundant cyanotoxins present in diverse water systems. They have been the cause of human and animal health hazards and even death. Development of suitable chemoprotectants against microcystin is essential considering the human health importance. In the present study, three agents cyclosporin-A (10mg/kg), rifampin (25mg/kg) and silymarin (400mg/kg) pre-treatment gave 100% protection against lethal dose of microcystin-LR (100 microg/kg). Various biochemical parameters were evaluated to study the recovery profile of protected animals at 1, 3, 7 and 14 days post-toxin treatment. There was significant depletion of hepatic glutathione in protected animals compared to control group till 7 days post-treatment but normalised by 14 days. Similarly enhanced hepatic lipid peroxidation, inhibition of protein phosphatase activity was observed till 3-7 days post-treatment in protected animals. Elevated levels of enzymes alanine amino transferase, lactate dehydrogenase and sorbitol dehydrogenase were observed in serum at 1 day post-treatment. All the biochemical variables reached control levels by 14 day post-treatment. Immunoblotting analyses of liver homogenates showed microcystin-protein phosphatase adduct in liver samples of toxin treated as well as antidote-protected animals. The adduct could be seen even after 14 days post-toxin treatment. The study shows that though cyclosporin-A, rifampin and silymarin could offer 100% protection against microcystin-LR induced lethality many of the toxic manifestations are persistent and could not be reversed till 7 days.

[1]  J. Bartram,et al.  Health risks caused by freshwater cyanobacteria in recreational waters. , 2000, Journal of toxicology and environmental health. Part B, Critical reviews.

[2]  R. Hilf,et al.  A fluorometric method for determination of oxidized and reduced glutathione in tissues. , 1976, Analytical biochemistry.

[3]  O. H. Lowry,et al.  Protein measurement with the Folin phenol reagent. , 1951, The Journal of biological chemistry.

[4]  Y. Ueno,et al.  Detection and identification of metabolites of microcystins formed in vivo in mouse and rat livers. , 1996, Chemical research in toxicology.

[5]  R. Vijayaraghavan,et al.  Comparative toxicity evaluation of cyanobacterial cyclic peptide toxin microcystin variants (LR, RR, YR) in mice. , 2003, Toxicology.

[6]  D. Dietrich,et al.  Cyanobacterial toxins: removal during drinking water treatment, and human risk assessment. , 2000, Environmental health perspectives.

[7]  S. Stohs,et al.  Evaluation of potential chemoprotectants against microcystin‐LR hepatotoxicity in mice , 1991, Journal of applied toxicology : JAT.

[8]  Shun-zhang Yu Primary prevention of hepatocellular carcinoma , 1995, Journal of gastroenterology and hepatology.

[9]  L. Clougherty,et al.  Operation of platinum-palladium catalysts with leaded gasoline. , 1975, Environmental health perspectives.

[10]  A. Havt,et al.  Renal effects of supernatant from rat peritoneal macrophages activated by microcystin-LR: role protein mediators. , 2003, Toxicon : official journal of the International Society on Toxinology.

[11]  A. Jana,et al.  Freshwater cyanobacterium Microcystis aeruginosa (UTEX 2385) induced DNA damage in vivo and in vitro. , 1998, Environmental toxicology and pharmacology.

[12]  N. Kaplowitz,et al.  Microcystin uptake and inhibition of protein phosphatases: effects of chemoprotectants and self-inhibition in relation to known hepatic transporters. , 1995, Toxicology and applied pharmacology.

[13]  N. Berndt,et al.  In vivo and in vitro binding of microcystin to protein phosphatases 1 and 2A. , 1995, Biochemical and biophysical research communications.

[14]  J. Eriksson,et al.  Identification of protein phosphatase 2A as the primary target for microcystin‐LR in rat liver homogenates , 1994, FEBS letters.

[15]  Takayoshi Suzuki,et al.  Genotoxicity of microcystin-LR in human lymphoblastoid TK6 cells. , 2004, Mutation research.

[16]  R. Bhattacharya,et al.  The cyanobacterial toxin microcystin-LR induced DNA damage in mouse liver in vivo. , 1996, Toxicology.

[17]  K. Yagi,et al.  Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. , 1979, Analytical biochemistry.

[18]  P. Casey,et al.  Cyclosporin A--a chemoprotectant against microcystin-LR toxicity. , 1990, Toxicology letters.

[19]  D. Hartshorne,et al.  Hepatocyte deformation induced by cyanobacterial toxins reflects inhibition of protein phosphatases. , 1990, Biochemical and biophysical research communications.

[20]  W. Ding,et al.  Role of oxidative stress and mitochondrial changes in cyanobacteria-induced apoptosis and hepatotoxicity. , 2003, FEMS microbiology letters.

[21]  W. Carmichael,et al.  Human intoxication by microcystins during renal dialysis treatment in Caruaru-Brazil. , 2002, Toxicology.

[22]  D. Mountfort,et al.  Evaluation of the fluorometric protein phosphatase inhibition assay in the determination of okadaic acid in mussels. , 1999, Toxicon : official journal of the International Society on Toxinology.

[23]  G. Codd,et al.  Cyanobacterial toxins and human health , 1994 .

[24]  W. Carmichael,et al.  Liver tumor promotion by the cyanobacterial cyclic peptide toxin microcystin-LR , 2005, Journal of Cancer Research and Clinical Oncology.

[25]  R M Dawson,et al.  The toxicology of microcystins. , 1998, Toxicon : official journal of the International Society on Toxinology.

[26]  D. G. Adams,et al.  Prophylaxis of cyanobacterial and mushroom cyclic peptide toxins. , 1989, The Journal of pharmacology and experimental therapeutics.